Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
0.280
+0.043 (18.34%)
At close: Jun 26, 2026, 4:00 PM EDT
0.210
-0.071 (-25.18%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Jupiter Neurosciences Employees
Jupiter Neurosciences had 5 employees as of December 31, 2025. The number of employees increased by 1 or 25.00% compared to the previous year.
Employees
5
Change (1Y)
1
Growth (1Y)
25.00%
Revenue / Employee
$8,090
Profits / Employee
-$1,835,598
Market Cap
12.16M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5 | 1 | 25.00% |
| Dec 31, 2024 | 4 | 0 | - |
| Dec 31, 2023 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| OSR Health | 22 |
| Theriva Biologics | 16 |
| CalciMedica | 16 |
| BioRestorative Therapies | 14 |
| Kiora Pharmaceuticals | 13 |
| Psyence Biomedical | 12 |
| Aprea Therapeutics | 8 |
| Intensity Therapeutics | 7 |
JUNS News
- 1 day ago - Jupiter Neurosciences files to sell 16M shares of common stock for holders - TheFly
- 4 weeks ago - Jupiter Neurosciences commences patient enrollment in RESET trial - TheFly
- 4 weeks ago - Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson's Disease - GlobeNewsWire
- 4 weeks ago - D. Boral Capital Acted as Exclusive Placement Agent to Jupiter Neurosciences, Inc. (Nasdaq:JUNS) in Connection with its ~$2 Million Registered Direct Offering - Accesswire
- 5 weeks ago - Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering - GlobeNewsWire
- 5 weeks ago - Jupiter Neurosciences announces pricing of $2M registered direct offering - TheFly
- 5 weeks ago - Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering - GlobeNewsWire
- 5 weeks ago - Jupiter Neurosciences to acquire licensing rights to ALA-002 for $3.33M upfront - TheFly